Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity

Visceral leishmaniasis is a severe parasitic disease that is one of the most neglected tropical diseases

From:
Department for International Development
Published
1 January 2015
Document Type:
Journal Article
Theme:
Health
Authors:
Brown, A., Cao, Y., Maes, L., Mowbray, C., Braillard, S., Feijens, P.B., Gardner, J.M., Gibson, K., Glossop, P., Hua, W., Matheeussen, A., Mills, J., Morgans, G., Speed, W., Whitlock, G.

Abstract

Visceral leishmaniasis is a severe parasitic disease that is one of the most neglected tropical diseases. Treatment options are limited, and there is an urgent need for new therapeutic agents. Following an HTS campaign and hit optimization, a novel series of amino-pyrazole ureas has been identified with potent in vitro antileishmanial activity. Furthermore, compound 26 shows high levels of in vivo efficacy (90%) against Leishmania infantum, thus demonstrating proof of concept for this series.

Citation

Mowbray, C.; Braillard, S.; Speed, W.; Glossop, P.; Whitlock, G.; Gibson, K.; Mills, J.; Brown, A.; Gardner, J.M.; Cao, Y.; Hua, W.; Morgans, G.; Feijens, P.B.; Matheeussen, A.; Maes, L. Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity. Journal of Medicinal Chemistry (2015) 58 (24) 9615-9624. [DOI: 10.1021/acs.jmedchem.5b01456]

Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity

Updates to this page

Published 1 January 2015
Contents